ENANTA PHARMACEUTICALS INC
ENTA·29251M106·US·Common Stock·Healthcare - Biotechnology-13D/G
ENTA (ENANTA PHARMACEUTICALS INC) is held by 75 institutional investors as of Q2 2026. Largest holders: Jupiter Topco LLC ($53.3M), BlackRock, Inc. ($47.3M), FARALLON CAPITAL MANAGEMENT, L.L.C. ($35.3M). Net institutional sentiment: Mixed.
75
Holders
(5 Elite)
$266.9M
Total Value
56% (71)
Consensus
40 buying - 31 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 14, 2026 · Insiders Aug 10, 2026 · Activists Aug 14, 2026 · Congress none
ActivistDTDeep Track Capital, LP5.0%Aug 14, 2026
InsiderRTRottinghaus Scott T.Tax 1K shAug 8, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 81
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer